Astrocyte-Derived TNF-α-Activated Platelets Promote Cerebral Ischemia/Reperfusion Injury by Regulating the RIP1/RIP3/AKT Signaling Pathway

Mol Neurobiol. 2022 Sep;59(9):5734-5749. doi: 10.1007/s12035-022-02942-z. Epub 2022 Jul 4.

Abstract

Ischemic stroke is a clinical syndrome caused by the disruption of blood flow into cerebral tissues and is associated with high disability and mortality rates. Studies have established the pathological role of platelets in cerebral ischemia/reperfusion (I/R) injury, although the underlying mechanism of action remains largely unclear. In this study, we created an I/R mouse model via middle cerebral artery occlusion and reperfusion (MCAO/R) and analyzed the transcriptomic profiles of the ipsilateral and contralateral cortices using RNA-seq. We found that cerebral I/R injury induced platelet invasion and accumulation in the cerebral cortex by stimulating TNF-α secretion from activated astrocytes in the ischemic region, while TNF-α expression enhanced platelet reactivity through the RIP1/RIP3/AKT pathway. Furthermore, the inoculation of TNF-α-stimulated platelets aggravated I/R injury in mice, whereas the administration of anti-TNF-α antibodies at the onset of reperfusion alleviated ischemic damage. The RNA-seq results further showed that AP-1 transcriptionally activated TNF-α in the I/R-injured cortex by directly binding to the promoter region. These findings provide novel insights into the pathological role of platelets activated by reactive astrocyte-derived TNF-α in cerebral I/R injury.

Keywords: AP-1; Astrocytes; Ischemic stroke; Platelet; RIP1/RIP3/AKT pathway; TNF-α.

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Brain Ischemia* / pathology
  • GTPase-Activating Proteins
  • Infarction, Middle Cerebral Artery / pathology
  • Mice
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Reperfusion Injury* / pathology
  • Signal Transduction
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • GTPase-Activating Proteins
  • Ralbp1 protein, mouse
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factor-alpha
  • Proto-Oncogene Proteins c-akt
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Ripk3 protein, mouse